TLR4 and neoplasm: As mentioned earlier, activated TLR2 or TLR4 in OSCC can trigger the production of IL-6 and other STAT3-activating factors that then act in autocrine fashion on the OSCC receptors, which is another major cell-intrinsic pro-tumor benefit of TLR activity.